Insider Selling: Axon Enterprise (NASDAQ:AXON) CEO Sells $10,000,000.00 in Stock

Axon Enterprise, Inc (NASDAQ:AXONGet Free Report) CEO Patrick Smith sold 20,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the transaction, the chief executive officer owned 3,060,997 shares in the company, valued at approximately $1,530,498,500. The trade was a 0.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $447.59 on Thursday. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91. The company has a market cap of $36.08 billion, a PE ratio of 179.76, a PEG ratio of 8.23 and a beta of 1.45. The company’s 50-day moving average is $409.55 and its two-hundred day moving average is $490.06.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.47 EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Institutional Trading of Axon Enterprise

Large investors have recently bought and sold shares of the business. New Millennium Group LLC bought a new stake in Axon Enterprise during the 3rd quarter worth approximately $29,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise during the 2nd quarter worth approximately $37,000. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the 4th quarter worth approximately $28,000. Sound Income Strategies LLC increased its stake in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Finally, Camelot Portfolios LLC bought a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. 79.08% of the stock is owned by institutional investors.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on AXON. UBS Group lowered their price target on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. Citizens Jmp lowered their price target on Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating for the company in a research note on Thursday, May 7th. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research note on Thursday, May 7th. TD Cowen lowered their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. Finally, Royal Bank Of Canada lowered their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $712.75.

Read Our Latest Analysis on Axon Enterprise

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Recommended Stories

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.